Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
ConditionGastric Ulcer
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age19+
SponsorAddpharma Inc.
About this trial
The study compare and evaluate the safety and pharmacokinetic characteristics of a single dose administration of 'AD-115A' or 'AD-1151' in healthy adults.
Eligibility criteria
Qualifiers
The Age equal to or greater than 19 in healthy volunteers at the time of screening visit
Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
Disqualifiers
Individuals who have taken drugs that induce (e.g., barbiturates) or inhibit drug-metabolizing enzymes within 30 days prior to the start of the study (first dosing day), or have taken drugs that may affect this study within 10 days prior to the start of the study (first dosing day)
Other exclusions applied
Trial design
Treatments tested in this trial
- AD-115A, AD-1151
Treatment groups
46 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov